AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ROSIGLITAZONE / METFORMINE

20 registrations across 1 African market— 20 active

Markets with ROSIGLITAZONE / METFORMINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive
AVANDAMET
COMPRIME PELLICULE
🇲🇦Moroccoactive

ROSIGLITAZONE / METFORMINE in Africa — Regulatory Overview

ROSIGLITAZONE / METFORMINE is registered across 1 African markets with 20 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 20 registrations, 20 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.